Noboru Ashida

Dr. Noboru Ashida


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2011 in Nature Communications
Verified
Journal Article
Open access
PDF file
NANoboru Ashida
Noboru Ashida
SSSucharita SenBanerjee
Sucharita SenBanerjee
SKShohta Kodama
Shohta Kodama
SFShi Yin Foo
Shi Yin Foo
MCMatthew Coggins
Matthew Coggins
ARAnthony Rosenzweig
Anthony Rosenzweig
Vascular endothelium provides a selective barrier between the blood and tissues, participates in wound healing and angiogenesis, and regulates tissue recruitment of inflammatory cells. Nuclear factor (NF)-κB transcription factors are pivotal regulators of survival and inflammation, and have been suggested as potential therapeutic targets in cancer and inflammatory diseases. Here we show that mice lacking IKKβ, the primary kinase mediating NF-κB activation, are smaller than littermates and born at less than the expected Mendelian frequency in association with hypotrophic and hypovascular placentae. IKKβ-deleted endothelium manifests increased vascular permeability and reduced migration. Surprisingly, we find that these defects result from loss of kinase-independent effects of IKKβ on activation of the serine-threonine kinase, Akt. Together, these data demonstrate essential roles for IKKβ in regulating endothelial permeability and migration, as well as an unanticipated connection between IKKβ and Akt signalling.

9 January 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
IAIsehaq Al‐Huseini
Isehaq Al‐Huseini
NANoboru Ashida
Noboru Ashida
TKTakeshi Kimura
Takeshi Kimura
Background: Vascular calcification was previously considered as an advanced phase of atherosclerosis; however, recent studies have indicated that such calcification can appear in different situations. Nevertheless, there has been a lack of mechanistic insight to explain the difference. For example, the roles of nuclear factor‐κB, a major regulator of inflammation, in vascular calcification are poorly explored, although its roles in atherosclerosis were well documented. Herein, we investigated the roles of nuclear factor‐κB signaling in vascular calcification. Methods and Results: We produced mice with deletion of IKK β, an essential kinase for nuclear factor‐κB activation, in vascular smooth muscle cells (VSMCs; KO mice) and subjected them to the CaCl 2 ‐induced aorta injury model. Unexpectedly, KO mice showed more calcification of the aorta than their wild‐type littermates, despite the former's suppressed nuclear factor‐κB activity. Cultured VSMC s from the aorta of KO mice also showed significant calcification in vitro. In the molecular analysis, we found that Runt‐related transcription factor 2, a transcriptional factor accelerating bone formation, was upregulated in cultured VSMC s from KO mice, and its regulator β‐catenin was more activated with suppressed ubiquitination in KO VSMC s. Furthermore, we examined VSMC s from mice in which kinase‐active or kinase‐dead IKK β was overexpressed in VSMC s. We found that kinase‐independent function of IKK β is involved in suppression of calcification via inactivation of β‐catenin, which leads to suppression of Runt‐related transcription factor 2 and osteoblast marker genes. Conclusions: IKK β negatively regulates VSMC calcification through β‐catenin–Runt‐related transcription factor 2 signaling, which revealed a novel function of IKK β on vascular calcification.

28 May 2014 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DTDat Nguyen Tien
Dat Nguyen Tien
MKMasako Kishihata
Masako Kishihata
AYAyumu Yoshikawa
Ayumu Yoshikawa
AHAri Hashimoto
Ari Hashimoto
HSHisataka Sabe
Hisataka Sabe
NANoboru Ashida
Noboru Ashida
NF-κB is a major transcriptional factor regulating many cellular functions including inflammation; therefore, its appropriate control is of high importance. The detailed mechanism of its activation has been well characterized, but that of negative regulation is poorly understood. In this study, we showed AMAP1, an Arf-GTPase activating protein, as a negative feedback regulator for NF-κB by binding with IKKβ, an essential kinase in NF-κB signaling. Proteomics analysis identified AMAP1 as a binding protein with IKKβ. Overexpression of AMAP1 suppressed NF-κB activity by interfering the binding of IKKβ and NEMO, and deletion of AMAP1 augmented NF-κB activity. The activation of NF-κB induced translocation of AMAP1 to cytoplasm from cell membrane and nucleus, which resulted in augmented interaction of AMAP1 and IKKβ. These results demonstrated a novel role of AMAP1 as a negative feedback regulator of NF-κB, and presented it as a possible target for anti-inflammatory treatments.

1 February 2024 in Cell Cycle
Verified
Journal Article
Open access
MHMasayuki Harada
Masayuki Harada
KSKanae Su-Harada
Kanae Su-Harada
TKTakeshi Kimura
Takeshi Kimura
KOKoh Ono
Koh Ono
NANoboru Ashida
Noboru Ashida
Although the acute inflammatory response plays a crucial role in defense against pathogens and tissue repair, chronic inflammation has been linked with aging and age-associated diseases [1]. The nu...

15 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IAIsehaq Al-Huseini
Isehaq Al-Huseini
MHMasayuki Harada
Masayuki Harada
KNKiyoto Nishi
Kiyoto Nishi
DNDat Nguyen-Tien
Dat Nguyen-Tien
TKTakeshi Kimura
Takeshi Kimura
NANoboru Ashida
Noboru Ashida
Inflammation resulting from virus infection is the cause of myocarditis; however, the precise mechanism by which inflammation induces cardiac dysfunction is still unclear. In this study, we investigated the contribution of insulin signalling to inflammatory cardiac dysfunction induced by the activation of signalling by NF-κB, a major transcriptional factor regulating inflammation. We generated mice constitutively overexpressing kinase-active IKK-β, an essential kinase for NF-κB activation, in cardiomyocytes (KA mice). KA mice demonstrated poor survival and significant cardiac dysfunction with remarkable dilation. Histologically, KA hearts revealed increased cardiac apoptosis and fibrosis and the enhanced recruitment of immune cells. By molecular analysis, we observed the increased phosphorylation of IRS-1, indicating the suppression of insulin signalling in KA hearts. To evaluate the contribution of insulin signalling to cardiac dysfunction in KA hearts, we generated mice with cardiac-specific suppression of phosphatase and tensin homologue 10 (PTEN), a negative regulator of insulin signalling, in the KA mouse background (KA-PTEN). The suppression of PTEN successfully improved insulin signalling in KA-PTEN hearts, and interestingly, KA-PTEN mice showed significantly improved cardiac function and survival. These results indicated that impaired insulin signalling underlies the mechanism involved in inflammation-induced cardiac dysfunction, which suggests that it may be a target for the treatment of myocarditis.

7 July 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SIShinya Ikeda
Shinya Ikeda
SSSachiko Sugioka
Sachiko Sugioka
TKTakeshi Kimura
Takeshi Kimura
NANoboru Ashida
Noboru Ashida
The Cre-loxP system has been widely used for cell- or organ-specific gene manipulation, but it is important to precisely understand what kind of cells the recombination takes place in. Smooth muscle 22α (SM22α)-Cre mice have been utilized to alter genes in vascular smooth muscle cells (VSMCs), activated fibroblasts or cardiomyocytes (CMs). Moreover, previous reports indicated that SM22α-Cre is expressed in adipocytes, platelets or myeloid cells. However, there have been no report of whether SM22α-Cre recombination takes place in nonCMs in hearts. Thus, we used the double-fluorescent Cre reporter mouse in which GFP is expressed when recombination occurs. Immunofluorescence analysis demonstrated that recombination occurred in resting cardiac fibroblasts (CFs) or macrophages, as well as VSMCs and CMs. Flow cytometry showed that some CFs, resident macrophages, neutrophils, T cells, and B cells were positive for GFP. These results prompted us to analyze bone marrow cells, and we observed GFP-positive hematopoietic precursor cells (HPCs). Taken together, these results indicated that SM22α-Cre-mediated recombination occurs in resting CFs and hematopoietic cell lineages, including HPCs, which is a cautionary point when using SM22α-Cre mice.